{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
BLA103123
(1992)
Source URL:
First approved in 1992
Source:
BLA103123
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Vivotif by Emergent Biosolutions Berna Gmbh [Canada]
Source URL:
First approved in 1989
Source:
BLA103123
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT02876601: Phase 4 Interventional Completed Healthy Volunteers
(2017)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE